Organizational Strategies and Business Models: Better Biotechnology

Science Business: The Promise, the Reality, and the Future of Biotech

Pisano, Gary P.

  • チャプター
HBI

The scientific and commercial promise of biotechnology has been impeded by the way the business is structured and operated. What are the key strategic issues facing younger and more established biotechnology firms, specifically on questions of vertical integration and organizational boundaries? This chapter focuses on the strategies and business models biotech and established pharmaceutical companies might deploy to improve their performance and realize the industry potential to transform health care. This chapter is excerpted from "Science Business: The Promise, the Reality, and the Future of Biotech."

出版日
2006/11
領域
経営・戦略
ボリューム
27ページ
コンテンツID
CCJB-HBS-6610BC
オリジナルID
6610BC
ケースの種類
Press Chapter
言語
英語
カラー
製本の場合、モノクロ印刷での納品となります。

関連ケース